State-level insurance coverage expands for AD biomarker testing (Mississippi 'Jill's Law') [climaxing]
Key Questions
What is Mississippi's 'Jill's Law' regarding Alzheimer's?
Jill's Law mandates state insurance coverage for AD biomarker testing, effective July 1, 2026. It is the first state-level policy modeling access and equity for early detection.
Why is Jill's Law significant for Alzheimer's care?
It addresses Medicare gaps in covering blood-based AD tests that detect the disease years before symptoms. States like AZ, IL, TN are being watched, alongside the ASAP Act.
What are the current challenges with Medicare and AD biomarker testing?
Medicare does not cover simple blood tests for early Alzheimer's detection, limiting access despite their potential. Jill's Law sets a precedent for state insurance mandates.
MS 'Jill's Law' mandates AD biomarkers coverage eff Jul 1, 2026. First state; models access/equity; watch AZ/IL/TN/CA SB950; Medicare gaps/ASAP Act.
Sources (2)
Updated Apr 8, 2026